Published in J Pediatr on May 01, 2001
A systematic review of secretin for children with autism spectrum disorders. Pediatrics (2011) 1.60
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr (2013) 1.47
Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin. Arch Dis Child (2003) 1.31
Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord (2005) 1.00
Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular Med (2005) 0.99
Lack of benefit of intravenous synthetic human secretin in the treatment of autism. J Autism Dev Disord (2002) 0.87
Secretin as a treatment for autism: a review of the evidence. J Autism Dev Disord (2004) 0.81
Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. Cell Mol Neurobiol (2004) 0.81
In children with autism, is intravenous secretin more effective than placebo in improving social skills, communication, behaviour or global functioning?: Part A: Evidence-based answer and summary. Paediatr Child Health (2004) 0.78
Inhibition of fear potentiated startle in rats following peripheral administration of secretin. Psychopharmacology (Berl) (2003) 0.78
Short report: Autistic gastrointestinal and eating symptoms treated with secretin: a subtype of autism. Clin Pract Epidemiol Ment Health (2005) 0.75
The central mechanisms of secretin in regulating multiple behaviors. Front Endocrinol (Lausanne) (2014) 0.75
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet (1999) 3.92
Leg ulcers: epidemiology and aetiology. Br J Surg (1986) 3.91
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut (2005) 3.86
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res (1992) 2.99
Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis (2000) 2.77
Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol (2001) 2.64
Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet (1972) 2.13
Venous leg ulcers: a prognostic index to predict time to healing. BMJ (1992) 2.05
Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am J Gastroenterol (2001) 1.94
Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol (2001) 1.87
Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) (1983) 1.75
Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m(7) guanosine cap. Mol Cell Biol (2001) 1.68
Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc Natl Acad Sci U S A (1996) 1.66
EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc (2000) 1.62
Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Surgery (1980) 1.61
Implications of suspicious findings in breast cancer screening. Arch Surg (1975) 1.60
Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc (2000) 1.57
Visualization of neuropeptide expression, transport, and exocytosis in Drosophila melanogaster. J Neurobiol (2001) 1.54
Botulism in a pregnant intravenous drug abuser. Anaesthesia (2006) 1.49
Which breast to biopsy: an expanding dilemma. Ann Surg (1976) 1.49
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47
Chronic paroxysmal hemicrania in a child. Headache (1994) 1.47
Origin of H1 linker histones. FASEB J (2001) 1.46
Images in clinical medicine. Osteoporosis in a woman of the early Bronze Age. N Engl J Med (1995) 1.41
Eukaryotic expression: developments for structural proteomics. Acta Crystallogr D Biol Crystallogr (2006) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol (1983) 1.40
The design, physical properties and clinical utility of an iris collimator for robotic radiosurgery. Phys Med Biol (2009) 1.39
Plant growth in elevated CO2 alters mitochondrial number and chloroplast fine structure. Proc Natl Acad Sci U S A (2001) 1.39
Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res (1993) 1.37
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect (2009) 1.31
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
The use of venous pressure measurements and directional doppler recordings in distinguishing between superficial and deep valvular incompetence in patients with deep venous insufficiency. Br J Surg (1973) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
The lipopolysaccharide of Shigella bacteria as a virulence factor. Rev Infect Dis (1991) 1.29
Occult carcinoma of the breast masquerading as primary adenocarcinoma of the small intestine. A case report. J Clin Gastroenterol (1988) 1.28
Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. Clin Infect Dis (1999) 1.27
Interactions of phage P22 tails with their cellular receptor, Salmonella O-antigen polysaccharide. Biophys J (1996) 1.26
Deterministic quantum teleportation with feed-forward in a solid state system. Nature (2013) 1.25
The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand (1982) 1.25
Cofractionation of the TATA-binding protein with the RNA polymerase III transcription factor TFIIIB. Nucleic Acids Res (1992) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol (1980) 1.21
The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene (2011) 1.17
Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res (1994) 1.14
Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis (2006) 1.14
Prevention and treatment of colorectal cancer: pay now or pay later. Ann Intern Med (2000) 1.13
Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast. Appl Microbiol Biotechnol (1998) 1.12
Intracardiac, intravascular, two-dimensional, high-frequency ultrasound imaging of pulmonary artery and its branches in humans and animals. Circulation (1990) 1.12
Effects of elevated atmospheric CO2 concentration on leaf dark respiration of Xanthium strumarium in light and in darkness. Proc Natl Acad Sci U S A (2001) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Gastroesophageal reflux during gastrostomy feeding. Gastroenterology (1994) 1.12
Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing D-galactose 4,6-cyclophosphate. Eur J Biochem (1995) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Three-dimensional and four-dimensional transesophageal echocardiographic imaging of the heart and aorta in humans using a computed tomographic imaging probe. Echocardiography (1992) 1.11
Rapid detection of Vibrio cholerae O139 Bengal from stool specimens by PCR. J Clin Microbiol (1997) 1.10
The metabolism of choline by a sympathetic ganglion. Can J Physiol Pharmacol (1969) 1.10
Common and unique transcription factor requirements of human U1 and U6 snRNA genes. EMBO J (1993) 1.10
Rapid transbilayer movement of fluorescent phospholipid analogues in the plasma membrane of endocytosis-deficient yeast cells does not require the Drs2 protein. Eur J Biochem (1999) 1.10
The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis. Cell Death Differ (2007) 1.09
Corynebacterium tuberculostearicum: a potentially misidentified and multiresistant Corynebacterium species isolated from clinical specimens. J Clin Microbiol (2012) 1.09
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09
Letter: Incompressible vessels. Lancet (1976) 1.09
Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae. Clin Microbiol Infect (2006) 1.08
Phage specific for Vibrio cholerae O139 Bengal. J Clin Microbiol (1996) 1.08
Control and tomography of a three level superconducting artificial atom. Phys Rev Lett (2010) 1.08
Retracted Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene (2007) 1.08
A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost (1992) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
IgA and IgG reticulin antibodies in coeliac and non-coeliac patients. Gut (1977) 1.08
Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc (2001) 1.07
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect Immun (1985) 1.05
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
[OSCE in the neurology clerkship. Experiences at the neurological department of the university hospital Erlangen]. Fortschr Neurol Psychiatr (2008) 1.03
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Distribution of bacteria in the epidermal layers and hair follicles of the human skin. Skin Pharmacol Physiol (2011) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Antithrombin III deficiency causing postsplenectomy mesenteric venous thrombosis coincident with thrombocytopenia. Ann Surg (1977) 1.02
Enzymatic synthesis and isolation of thymidine diphosphate-6-deoxy-D-xylo-4-hexulose and thymidine diphosphate-L-rhamnose. Production using cloned gene products and separation by HPLC. Eur J Biochem (1992) 1.01
Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol (1995) 1.01
A common cause for a common phenotype: the gatekeeper hypothesis in fetal programming. Med Hypotheses (2011) 1.01
Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal. Eur J Biochem (1997) 1.01
Effects of peer-assisted training during the neurology clerkship: a randomized controlled study. Eur J Neurol (2008) 1.01
Structural studies of the O-antigenic polysaccharide from Escherichia coli O139. Eur J Biochem (1998) 1.01
Two distinct effects on neurotransmission in a temperature-sensitive SNAP-25 mutant. EMBO J (2001) 1.01
Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol (1989) 1.00
Graduated compression and its relation to venous refilling time. Br Med J (Clin Res Ed) (1987) 1.00
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
Cloning and sequence of a region of Vibrio cholerae O139 Bengal and its use in PCR-based detection. J Clin Microbiol (1996) 0.98
Studies on the haemopoietic toxicity of nitrous oxide in man. Br J Haematol (1983) 0.97
Identification of Bacteroides fragilis by indirect immunofluorescence. Med Microbiol Immunol (1979) 0.97
Multiplane transesophageal echocardiography. Imaging planes, echocardiographic anatomy, and clinical experience with a prototype phased array OmniPlane probe. Echocardiography (1992) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Expression of the Shigella dysenteriae type-1 lipopolysaccharide repeating unit in Escherichia coli K12/Shigella dysenteriae type-1 hybrids. Eur J Biochem (1993) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Pacemaker lead infection and vertebral osteomyelitis presumed due to Cardiobacterium hominis. Clin Infect Dis (1998) 0.96